Thelium Therapeutics

0 followers


Thelium is committed to the development of non-immunosuppressive small molecule therapies for treatment of inflammatory diseases.


Their world class team has 2 decades of intestinal epithelial barrier expertise combined with a track record of success spanning over 35 INDs and 6 commercial products.

Industries

Headquarters

Stage

Employees

Links

Org chart

Miro Brajenovic

Collapse
Roman Sakowicz
Chief Technology Officer & Head, Discovery
Vallen Graham
Co-Founder & Head, Research
Petr Jansa
Head, Medicinal Chemistry